How did the 21st Century Cures Act of 2016 aid the FDA in drug quality and safety?

The 21st Century Cures Act of 2016 significantly advanced the role of patient perspectives in the approval and regulatory processes of drug development, which aligns with the correct choice. By incorporating patient feedback and clinical experience into decision-making, the FDA can better understand the real-world impact of drugs on patients' lives. This focused approach means that the agency can prioritize therapies that address patient needs and outcomes more effectively, ultimately improving drug quality and safety.

Patient perspectives contribute valuable insights about the effectiveness, benefits, and potential side effects of treatments in everyday use, which are not always captured in traditional clinical trials. This inclusion supports a more patient-centered approach to healthcare, fostering innovation while ensuring safety and quality in drug development. By acknowledging the voice of the patient in the decision-making process, the FDA increases the likelihood that approved drugs will be relevant and beneficial to those using them.